Unicycive Therapeutics, Inc. (UNCY) NASDAQ
7.23
-0.37(-4.87%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Unicycive Therapeutics, Inc.
Address
4300 El Camino Real
Los Altos, CA 94022
United States of America (the)
Phone
650 351 4495
Website
Sector
Healthcare
Industry
Biotechnology
Employees
22
First IPO Date
July 12, 2021
Key Executives
| Name | Title | Pay | Year Born |
| Shalabh K. Gupta | Founder, Chairman, Chief Executive Officer & President | 1.06M | 1974 |
| John W. Townsend | Chief Financial Officer | 197,864 | 1962 |
| Douglas Jermasek | Executive Vice President of Corporate Strategy | 440,138 | 1961 |
| Pramod Gupta | Executive Vice President of Pharmaceutical and Business Operations | 666,900 | 1960 |
Description
Unicycive Therapeutics, Inc., a biotechnology company, engages in developing novel therapies for kidney diseases in the United States. It is developing Renazorb for treatment of hyperphosphatemia in patients with chronic kidney disease; and UNI 494, for treatment of acute kidney injury. The company was incorporated in 2016 and is based in Los Altos, California.
